SEC Form 4 · accession 0001192482-18-000165
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Thomas Heffernan
Officer — Chairman, President and CEO · Director
Period of report
Apr 19, 2018
Accepted (ET)
Apr 23, 2018 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 19, 2018 | S | 44,300 | $26.00 | D | 545,893 | D | |
| Common Stock | Apr 19, 2018 | S | 100 | $26.01 | D | 545,793 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended.